D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$354M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$309M |
| 3 |
Microsoft
MSFT
|
+$307M |
| 4 |
Automatic Data Processing
ADP
|
+$266M |
| 5 |
Citigroup
C
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$567M |
| 2 |
Fidelity National Information Services
FIS
|
+$410M |
| 3 |
Medtronic
MDT
|
+$359M |
| 4 |
Amazon
AMZN
|
+$297M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 12.73% |
| 3 | Healthcare | 11.62% |
| 4 | Financials | 8.02% |
| 5 | Industrials | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
CytomX Therapeutics
CTMX
$690M
| $2.49M | ﹤0.01% |
337,004
+4,810
| +1% | +$47.4K |
|
2152
PUT
Ovintiv
OVV
$17B
| $2.48M | ﹤0.01% |
108,000
+16,000
| +17% | +$366K |
|
2153
CALL
Synchrony
SYF
$24.4B
| $2.48M | ﹤0.01% |
72,800
+51,600
| +243% | +$1.77M |
|
|
CAI
2154
DELISTED
CAI International, Inc.
CAI
| $2.47M | ﹤0.01% |
113,382
-48,000
| -30% | -$1.06M |
|
2155
Amphenol
APH
$185B
| $2.47M | ﹤0.01% |
102,232
-372,208
| -78% | -$8.58M |
|
2156
Center Bancorp
CNOB
$1.65B
| $2.46M | ﹤0.01% |
111,012
-3,095
| -3% | -$67.2K |
|
2157
PUT
ATI
ATI
$24.3B
| $2.46M | ﹤0.01% |
+121,600
| New | +$2.57M |
|
2158
CALL
Viatris
VTRS
$20.8B
| $2.46M | ﹤0.01% |
124,200
+62,100
| +100% | +$1.22M |
|
|
SEMG
2159
PUT
DELISTED
SEMGROUP CORPORATION
SEMG
| $2.45M | ﹤0.01% |
150,000
+50,000
| +50% | +$584K |
|
2160
PUT
Aptiv
APTV
$12.3B
| $2.45M | ﹤0.01% |
28,000
| – | – |
|
2161
PUT
BorgWarner
BWA
$12.8B
| $2.44M | ﹤0.01% |
+75,658
| New | +$2.44M |
|
2162
CALL
Cummins
CMI
$83.6B
| $2.44M | ﹤0.01% |
15,000
-3,700
| -20% | -$592K |
|
2163
Red Robin
RRGB
$139M
| $2.44M | ﹤0.01% |
73,206
+51,460
| +237% | +$1.69M |
|
2164
UNIFI
UFI
$114M
| $2.43M | ﹤0.01% |
110,863
-22,337
| -17% | -$440K |
|
2165
Axsome Therapeutics
AXSM
$11.7B
| $2.43M | ﹤0.01% |
119,951
+85,195
| +245% | +$2.19M |
|
2166
Ralph Lauren
RL
$22.4B
| $2.43M | ﹤0.01% |
25,418
-40,817
| -62% | -$4.04M |
|
2167
Revvity
RVTY
$12.6B
| $2.43M | ﹤0.01% |
28,483
-51,843
| -65% | -$4.54M |
|
2168
Innospec
IOSP
$2.09B
| $2.42M | ﹤0.01% |
27,150
+6,556
| +32% | +$588K |
|
2169
PUT
Motorola Solutions
MSI
$72.1B
| $2.42M | ﹤0.01% |
14,200
+9,800
| +223% | +$1.68M |
|
2170
Ingles Markets
IMKTA
$1.72B
| $2.42M | ﹤0.01% |
62,192
+32,626
| +110% | +$1.16M |
|
2171
CALL
Tandem Diabetes Care
TNDM
$1.27B
| $2.41M | ﹤0.01% |
40,900
-14,800
| -27% | -$945K |
|
|
NXGN
2172
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.41M | ﹤0.01% |
153,862
-9,288
| -6% | -$154K |
|
|
BFX
2173
DELISTED
BowFlex Inc.
BFX
| $2.4M | ﹤0.01% |
1,779,017
+639,117
| +56% | +$1M |
|
|
HOLI
2174
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $2.39M | ﹤0.01% |
157,585
+95,155
| +152% | +$1.58M |
|
2175
UDR
UDR
$12.9B
| $2.39M | ﹤0.01% |
+49,349
| New | +$2.32M |
|
Similar funds
D.E. Shaw & Co's Q3 2019 Portfolio in Review
As of Q3 2019, D.E. Shaw & Co held 4,189 positions worth $81.2B, up 1.3% from $80.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2019 filing shows 550 new, 1,503 increased, 1,391 reduced and 422 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M. The largest sale was Anadarko Petroleum, an estimated $567M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M.
- D.E. Shaw & Co added most to PayPal in Q3 2019, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2019 reduction was Fidelity National Information Services, cutting an estimated $410M.
- D.E. Shaw & Co fully exited Anadarko Petroleum in Q3 2019, selling an estimated $567M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $81.2B portfolio in Q3 2019.
- D.E. Shaw & Co opened 550 new positions and closed 422 in Q3 2019.
- D.E. Shaw & Co's portfolio value rose 1.3% quarter-over-quarter to $81.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.